Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Unit price / market price
-
$0.9441
-
Total 13F principal
-
$42,911,000
-
Principal change
-
-$2,189,000
-
Total reported value
-
$40,606,333
-
Number of holders
-
17
-
Value change
-
-$2,036,900
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q1 2024
As of 31 Mar 2024 IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 had 17 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $42,911,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Sonora Investment Management Group, LLC, MORGAN STANLEY, PALISADE CAPITAL MANAGEMENT, LP, MACQUARIE GROUP LTD, Penn Mutual Asset Management, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, HighTower Advisors, LLC, WELLS FARGO & COMPANY/MN, CITIGROUP INC, and Kohlberg Kravis Roberts & Co. L.P..
This table shows 17 bond principal holders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.